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Abstract 
Production of collagenase and collagenase inhibitors by the explants of epi-
physeal, metaphyseal and diaphyseal regions of embryonic chick limbs during 
development has been investigated. Collagenase-inhibitory activity was first de-
tected in the culture medium of the diaphyseal region of limbs at stage 36 where 
cartilage matrix erosion began to occur. However, neither active nor latent col-
lagenase was detected in the media of any regions examined. At stage 38 and 
later, the maximum production of the inhibitory activity was observed in the 
explants of metaphyseal region (growth cartilage), while collagenase production 
was only in the diaphyseal region. 
Two collagenase inhibitors were isolated and purified approximately 150 fold 
from the culture medium of stage 38 and 43 metaphyseal regions of limbs by 
anion- and cation-exchange chromatography followed by gel filtration. The in-
hibitors are cationic proteins with the same molecular weight of approximately 
25,000, but slight difference in molecular charge. They are heat-stable and in-
hibit collagenases from tadpole skin, chick bone and skin and human granulocytes 
and gelatinases from human granulocytes and chick skin as well as trypsin, but 
not Clostridium histolyticum collagenase. 
A possible function of the inhibitors in multistep regulations of the collagen-
degrading enzyme system at the region of os teo-chondral transition is discussed. 
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Introduction ". 
During the embryonic limb development, the skeleton is first formed in car-
tilage models which are destined to be resorbed and replaced by bone (Bloom and 
Fawcett, 1968). In the process of endochondral ossification, active transition of 
matrix from cartilage to bone is accompanied by degradation (of type II collagen) 
and synthesis of (type I) collagen, which is the major macromolecular component 
of extracellular matrix (Lutfi, 1971; Linsenmayer et a!., 1973; von der Mark et a!., 
1976). A possible mechanism for selective degradation of type II collagen at the 
proximate region of resorbing cartilage and newly forming osteoid tissue was 
reported by demonstrating the modulation of type II collagen degradation by 
collagenase by the presence of other type(s) of collagen (Hayashi et a!', 1980a; 
Hayashi et a!., 1980b). However, regulation mechanisms of collagenase activity 
during limb development remain obscure at present. 
This paper reports the production of collagenase and its inhibitor by the ex-
plants of epiphyseal, metaphyseal and diaphyseal regions of embryonic chick 
limbs during development. Inhibitory effect of partially purified collagenase in-
hibitor on other neutral proteases is also described. 
Materials 
DNP-Pro-Gln-Gly-Ile-Ala-Gly-Gln-D-Arg-OH (Peptide P) was obtained from 
the Protein Research Foundation, Minoh, Osaka. Tosylphenylchloromethyl-
ketone-treated trypsin (317 U/mg) was purchased from Worthington Biochemical 
Corporation, Freehold, New Jersey, U.S.A.; Clostridium histolyticum collagenase 
(1000 Mandl U/mg) from Seikagaku Kogyo Co., Ltd., Tokyo; urokinase (2000 
U/mg) from Midori-Juji Co., Ltd., Osaka; chymotrypsin (salt-free) from Nutri-
tional Biochemical Corporation, Cleveland, Ohio, U.S.A. Swine pancreatic elastase 
(crystallized four times) from Eisai Co., Ltd., Tokyo; tosyl-L-arginine methyl-
ester from Fluka AG, Buchs, Switzerland; tosyllysylchloromethylketone (TLCK) 
from Sigma Chemical Co., St. Louis Missouri, U.S.A and Ham's F-12 (modified, 
lot No. FP1083003) from Flow Laboratories, Rockville, Maryland, U.S.A. All 
other chemicals used were of analytical grade. Collagenase preparations from 
tadpole skin, chick skin, human granulocyte were obtained, as reported previously 
(Hori and Nagai, 1979; Kawamoto and Nagai, 1976; Kobayashi and Nagai, 
1978). Human granulocyte and chick skin gelatinases were prepared as described 
previously (Kobayashi and Nagai, 1978; Sunada and Nagai, 1980). Plasminogen 
was prepared from human plasma by lysine-Sepharose chromatography according 
to the methods of Deutsch and Mertz (1970) and Shiba (1976). 
,. Abbreviations: Peptide P, dinitrophenyl-L-prolyl-L-glutaminylglycyl-L-isoleucyl-L-
alanylglycyl-L-glutaminyl-D-arginine; SDS, sodium dodecylsulfate; TLCK, tosyllysyl-
chloromethylketone; TPCK, tosylphenylchloromethylketone, Tris-NaCl-CaCl2, 0.05 M 
Tris-HCl, pH 7.6, containing 0.15 M NaCl and 5 mM CaClt . 
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Methods 
Tissue Culture 
All procedures for tissue culture were carried out under sterile conditions. 
White Leghorn chick embryos were staged according to Hamburger and Hamilton 
(1951). The tibiae and femur from stage 33-43 chick embryos were resected, freed 
of the adherent connective tissue and further resected into two or three ana-
tomical regions, i.e., epiphyseal, metaphyseal and diaphyseal regions. Like regions 
were combined, sliced into small pieces (2 X 2 X 2 mm) and 0.15 g of each ex-
plant was spread upon a filter paper disc floating in 2 ml of modified Ham's 
F-12 medium supplemented with sodium ascorbate (50 ,ug/ml) (Kawamoto and 
Nagai, 1976) in a 60 mm Petri dish. These were cultured at 37°C in a humidified 
incubator under 5 % CO2 - 95 % air, changing the medium every second day. 
For preparation of collagenase and collagenase inhibitor, stage 43 chick embryos 
were used to obtain larger quantities of the materials. Explants of 0.5 g tissues 
were cultured in a 100 mm Petri dish containing 9 ml of medium. The harvested 
media were centrifuged at 6000 X g for 20 min to remove any floating tissue 
debris and stored at -20°C until used. 
Isolation of Chick Bone Collagenase 
All procedures for enzyme purification were carried out at 4--10 DC. The cul-
tured media, about 200 ml, of the diaphyseal region of stage 43 embryonic chick 
bones were treated with 3 M NaI (Shinkai and Nagai, 1977) to activate latent 
collagenase, then concentrated to 4 ml by ultrafiltration through a Diaflo UM-
10 membrane under a pressure of 1.5 kg/cm2 of N2 gas. The resulting media 
was centrifuged at 100,000 X g for 30 min, then applied on a Sephadex G-75 
superfine column (2.0 X 81 cm) equilibrated with 0.05 M Tris-HCI buffer, pH 
7.6, containing 0.15 M NaCI and 5 mM CaCl2 (Tris-NaCI-CaCI2). Aliquots of 
the effluent fractions were assayed for collagenase activity. 
Purification of Collagenase Inhibitor 
All procedures for the purification of collagenase inhibitor were carried out at 
4--10°C. Collagenase inhibitor was purified from the cultured media of the ex-
plants of the metaphyseal region of stage 43 embryonic chick bones. The har-
vested cultured media were dialyzed against 0.1 M Tris-HCI buffer, pH 8.0, 
containing 2 M urea, and centrifuged at 100,000 X g for 30 min. The supernatant, 
690 ml, was applied on a DEAE-cellulose (DE-32) column (2.6 X 25 cm) equili-
brated with the same buffer. The column was washed and two step elutions were 
carried out, the first with 0.1 M NaCI and then with 2.0 M NaC!. Aliquots of 
the effluent fractions were dialyzed against Tris-NaCI-CaCI2 buffer and assayed 
for collagenase inhibitory activity using purified tadpole enzyme (37 munits) 
(Hori and Nagai, 1979). The break-through fraction, the fractions containing 
inhibitory activity, were combined, concentrated to 118 ml with an Amicon 
Diaflo UM-10 membrane, dialyzed against 0.02 M Acetate buffer, pH 5.4, and 
applied on a Whatman CM-32 column (1.5 X 35.5 cm). The column was washed 
with 113 ml of the starting buffer and a 600 ml-linear gradient of 0 to 1.0 M NaCI 
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in the same buffer was used to elute the inhibitor. The fractions contammg 
collagenase inhibitory activity (peak A, tube numbers 42-44 and peak B, tube 
numbers 46-50) were pooled separately, dialyzed against Tris-NaCI-CaCI2 buffer 
containing 0.02 Ofo NaN3, concentrated to 4 ml with an Amicon Diaflo UM-l0 
membrane, then chromatographed on a Sephadex G-75 superfine column (2.0 X 
81 cm) equilibrated with Tris-NaCI-CaCI2 buffer. Aliquots (0.1 ml) of the ef-
fluent fractions were assayed for collagenase inhibitory activity. 
Assay of Collagenase Activity 
For collagenase assays the cultured medium was dialyzed against 3 M NaI in 
Tris-NaCI-CaCI2 buffer for 16 h to activate latent enzyme, then extensively 
dialyzed against Tris-NaCI-CaCI2 buffer without NaI. Collagenase activity was 
determined by measuring the release of soluble radioactivity from 14C-Iabeled 
reconstituted guinea-pig skin collagen fibrils (gel method, Nagai and Hori, 1972) 
or the release of radioactivity into the supernatant of 50 Ofo dioxane after enzyme 
digestion of 14C-Iabeled soluble collagen at 35°C (solution method, Terato 
et aI., 1976). One unit of collagenase activity is defined as the amount of pro-
tein necessary to degrade 1 /kg collagen per minute under the conditions em-
ployed. 
Assays of Peptidase and Gelatinolytic Activities 
Peptidase activity against Peptide P was assayed, as described previously (Masui 
et aI., 1977; Hori and Nagai, 1979). Gelatinolytic activity was assayed using 3H-
labeled heat-denatured polymeric collagen (gelatin) as a substrate (Sun ada and 
Nagai, 1980). The method is based on enzyme digestion of the gelatin at neutral 
pH and 37°C and selective extraction of the digestion products into 67 Ofo 
dioxane for determination of the radioactivity released. One unit of gelatinolytic 
activity is defined as the amount of protein degrading 1 fhg of gelatin per minute 
under the conditions employed. 
Determination of Protease-inhibiting Activity 
Protease-inhibiting activity of the cultured media of embryonic chick bones or 
their chromatographed fractions was determined by measuring the depression of 
enzyme activity of various proteases against 14C-labeled collagen (Nagai and 
Hori, 1972; Terato et aI., 1976), 3H-Iabeled heat-denatured polymeric collagen 
(Sunada and Nagai, 1980) or Peptide P (Masui et aI., 1977; Hori and Nagai, 
1979). One inhibition unit (IU) is expressed as the amount of protein required 
for 50 Ofo inhibition of 2 units of collagenase by the gel method. 
Electrophoresis 
Sodium dodecylsulfate (SDS)-polyacrylamide gel electrophoresis was carried 
out using a 6 Ofo gel in Tris-glycine buffer, pH 8.3, containing 0.1 Ofo SDS (Hayashi 
and Nagai, 1979). 
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Results 
Production of Collagenase and Collagenase Inhibitor by Embryonic Chick 
Limb Explants during Development 
Light microscopic observations on the developmental changes of embryonic 
chick limbs showed that by stage 33 most of the skeleton was composed of car-
tilage destined to be absorbed and replaced by bone. Around stage 36 the hyper-
trophic cartilage matrix of diaphysis began to disintegrate, was invaded by small 
blood vessels and was ensheathed in a thin collar of perichondral bone. By 
stage 38 marrow cavity of the shaft has expanded a great deal and active u'ansi-
tion of matrix from cartilage to bone occurred in the metaphyseal region (Fig. 1, 
bottom). 
To elucidate whether the transition resulted from the manifestation of col-
lagenase activity during this morphogenesis, the culture media of the explants 
STAGE 33 STAGE 36 STAGE 38 
o 
o 
INCUBATION TIME(DAYS) 
I I I 
E MOM E E M o M E 
Fig. 1. Production of collagenase and collagenase inhibitor by the explants of different 
anatomical regions of embryonic chick limbs at three different stages. Culture medium 
was refreshed every second day. Collagenase activity in a series of the cultured media was 
assayed after 3 M NaI treatment to activate latent enzyme, Epiphyseal (0), metaphyseal 
(f::,) and diaphyseal (0) regions of limbs. Collagenase inhibitory activity was assayed by 
incubating tadpole collagenase (37 munits/ml) with 0.1 ml of cultured medium after dialysis 
against Tris-NaCI-CaCI2 buffer. Epiphyseal (e), metaphyseal (A) and diaphyseal (II1II) 
regions, 
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of different anatomical regions of developing limbs were assayed for collagenase 
and its inhibitory activities (Fig. 1). By stage 36 no or little collagenase activity 
was detected within the period of culture (14 days) of any explants. At stage 38 
collagenase activity emerged only in the culture medium of the explants of the 
diaphyseal region after 6 days in culture. The diaphyseal region at this stage 
consists mainly of new bone matrix and bone marrow cells. The enzyme activity 
became maximum at 12th day in culture and declined thereafter. Culture media 
from other two anatomical regions at this stage, epiphysis and metaphysis, did 
not show any detectable collagenase activity during culture period. On the other 
hand, collagenase-inhibitory activity was first detected in the culture medium of 
the diaphyseal region of limbs at stage 36, where cartilage matrix erosion began 
to occur. By stage 38 the inhibitor was released into culture medium more or 
less by the explants of all anatomical regions examined. At this stage the zone of 
matrix transition from cartilage to bone migrated to the metaphyseal region, 
producing the largest amount of collagenase inhibitor. The production of col-
lagenase and its inhibitor at stage 43 was quite similar to that by explants at 
stage 38 (data not shown). The collagenase inhibitor released from the meta-
physeal region retained its full inhibitory activity even after NaI treatment. 
Isolation and Purification of Collagenase Inhibitor 
Collagenase inhibitor could be highly purified from the culture medium of the 
explants of stage 38-43 metaphyseal (growth cartilage) regions using anion- and 
cation-exchange chromatography followed by gel filtration. On DE-32 column 
chromatography, most of collagenase inhibitory activity was recovered in the 
break-through fraction under the conditions described in "METHODS". The 
fractions eluted at either 0.1 M NaCl or 2.0 M NaCl showed no detectable in-
hibitory activity even after 10 fold concentration. Apparent recovery of the in-
hibitory activity in the break-through fraction was as high as 100 % (Table 1). 
Table 1. Purification and recovery of the collagenase inhibitor from the explants of the 
metaphyseal region of embryonic chick bones at stage 43 
Fractionation Total Total Collagenase inhibitory activity 
volume OD2,. Units Specific Purifi- Recovery 
(ml) (IU) activity cation (%) 
Culture medium 690 89.7 91.9 1.02 1 100 
DE-32 chromatography 920 36.8 112.3 3.05 3.0 122 
CM-32 chromatography 168 7.18 37.1 5.17 5.1 40.3 
Gel chromatography A 23 0.302 15.7 52.0 51.0 17.1 
Gel chromatography B 29 00400 19.3 48.3 47.3 21.0 
Figure 2 shows further purification of the inhibitor on a CM-32 column. Two 
major inhibitor peaks eluted at 0.22 M NaCl and 0.29 M NaCl concentrations 
were obtained. Although a small inhibitory activity was obtained at 0.13 M NaCl 
effluent fraction, no further characterization was performed with this fraction 
because of the limited amount of the material. The two major inhibitor frac-
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tions (A and B) were pooled separately, dialyzed, concentrated and applied on a 
Sephadex G-7S superfine column (Fig. 3). Either inhibitor was recovered at the 
same effluent fraction as a sharp peak corresponding to a molecular weight of 
Fig. 2. CM-cellulose column chro-
matography of growth cartilage 
collagenase inhibitor. Cultured me-
dium containing collagenase inhi-
bitory activity from the metaphy-
seal region of stage 43 embryonic 
chich limbs was first chroma to-
graphed on a DE-32 column as de-
scribed under "METHODS". The 
break-through fraction containing 
collagenase inhibitory activity was 
concentrated, dialyzed against 0.02 
M acetate buffer, pH 5.4, and 
chromatographed on a CM-32 col-
umn (1.5 x 35.5 cm) equilibrated 
with the same buffer. The column 
was washed until the absorbance 
at 280 nm reduced to base line. 
Elution was accomplished by ap-
plying a 600 ml linear gradient of 
o to 1.0 M NaCI. Effluent frac-
tions of 10.5 ml were collected at 
a flow rate of 16 ml/h. G, gradient 
and W, washing. 
Fig. 3. Sephadex G-75 superfine 
chromatography of growth carti-
lage collagenase inhibitor. Effluent 
fractions containing collagenase in-
hibitor from a CM-32 column 
(fraction A, tube numbers 41-44, 
and fraction B, tube numbers 46-50 
in Fig. 2) were pooled separately, 
dialyzed against Tris-NaCI-CaClz 
buffer, concentrated and applied on 
a Sephadex G-75 superfine column 
(2.0 x 81 cm) equilibrated with the 
same buffer. Effluent fractions of 
2.9 ml were collected at a flow rate 
of 7 ml/h. Aliquots (0.1 ml each) 
of the effluent fractions were in-
cubated with tadpole collagenase 
(90.6 munits for sample A, 0-0 
or 40.0 munits for sample B, 
0-0). AZ80111TI; -, A and-----, 
B. Vo, void volume; BSA, bovine 
serum albumin; OVA, ovalbumin; 
CHTG, chymotrypsinogen and 
CYTC, cytochrome C. 
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approximately 25,000. The specific actlVlty of the inhibitors recovered at the 
peak fractions (tube numbers 54 for A and 53 for B) were 143.8 IU and 148.0 IU, 
respectively. This indicates that both inhibitors were purified approximately 
150 fold, though the average specific activity of the inhibitor containing frac-
tions was about 50 IU (Table 1). Therefore, the peak fractions were employed for 
the following experiments. 
Kinetic Studies of Collagenase Inhibitor 
Using purified collagenase inhibitor (tube number 53 of B in Fig. 3) and tad-
pole collagenase (Hori and Nagai, 1979), effect of inhibitor concentrations on the 
rate of collagenase inhibition was studied by the gel method. As shown in Figure 
4, addition of the inhibitor to purified collagenase resulted in a dose-dependent 
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o 
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Fig. 4. Changes of collagenase activity as 
a function of inhibitor concentration. In a 
series of small test tubes containing 0.4 ml 
of 14C-labeled collagen gels, various 
amounts of purified growth cartilage in-
hibitor (tube No. 53 of sample B in Fig 3) 
was added, then enzyme reaction was 
started at 37°C by adding 36 munits (0), 
54 munits (6) or 90 munits (0) of tadpole 
collagenase. 
inhibition of enzyme activity and the degree of inhibition was inversely propor-
tional to enzyme concentration. However, with increasing inhibitor concentra-
tions, no longer proportional inhibition was observed and a large excess of the 
inhibitor was required to inhibit the enzyme completely. 
Time course of inhibition of tadpole collagenase by the inhibitor is shown in 
Figure 5. To a fixed amount of collagenase, increasing amounts of inhibitor were 
added and hydrolysis of reconstituted collagen fibrils was measured at selected 
periods. The hydrolysis was linear up to 24 h with or without inhibitor and the 
percentage of inhibition at individual inhibitor concentrations was nearly con-
stant throughout the assay period, indicating that both enzyme and inhibitor 
retained their activities during the period of the assay (48 h). 
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Fig. 5. Kinetic analysis of colla-
genase activity in the presence of 
growth cartilage inhibitor with 
various concentrations. In a series 
of small test tubes containing 
0.4 ml of HC-labeled collagen gels, 
o ,ul (0),25 ,ul (e), 50 ,ul (A) and 
100 ,ul (.) of the inhibitor was 
added and total volume was ad-
justed to 0.5 ml by adding Tris-
NaCI-CaClz buffer. Then, enzyme 
reaction was started by adding 
0.1 ml of tadpole collagenase (108 
munits) at 37°C. 
INCUBA TION TIME(HR) 
Action of Inhibitor on Collagenase and Other Neutral Proteases from Various 
Sources 
Action of an inhibitor on various collagenases and other neutral proteases was 
examined using collagen and gelatin as substrates. As summarized in Table 2, 
Table 2. Action of the collagenase inhibitor on collagenases from various tissues. The 
indicated amounts of various collagenases were incubated with 600,ug of HC-labeled 
collagen fibrils in a final volume of 600,u1 (Tris-NaCI-CaClz buffer) at 37°C for 30-50 h 
with or without added inhibitor (107 mID, 0.1 ml). When soluble collagen was used as a 
substrate, the enzymes were incubated with 400,ug of HC-labeled soluble collagen in a 
final volume of 400,u1 at 35°C for 28 h. After termination of the enzyme reaction by 
adding 20,u1 of 80 mM o-phenanthroline, an"equal volume of dioxane was added to the 
reaction mixture and the radioactivity in the supernatant was determined with a Beckman 
LS-9000 liquid scintillation system 
Enzyme source Collagenase activity against 
Amount Collagen fibrils 
(ng) Control + Inhi-
bitor 
(munits) (munits) 
Tadpole skin 1 3.8 32 9 
4.4 37 2 
Chick bone z 10,u1 75 7.5 
Chick skin 3 100,u1 21 9.2 
Human granulo-
cyte 4 25,u1 36 8.5 
Cl. histolyticum 5 37 37 
18400 units/mg protein (Hori and Nagai, 1979). 
3 3.70 units/OD,so nm. 
" 164 mID inhibitor was employed. 
Inhi-
bition 
(%) 
72 
95"· 
90 
56" 
77"" 
0 
Soluble collagen 
Control + Inhi- Inhi-
bitor bition 
(munits) (munits) (%) 
61 34 44 
91 15 84 
24.93 units/OD,so nm. 
45.90 units/ODz•o nm. 
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the inhibitor blocked the action of collagenase from tadpole skin, chick bone and 
skin as well as human granulocytes, but not bacterial collagenase. The most 
potent inhibition was observed with chick bone collagenase using either collagen 
fibrils or soluble collagen as substrates. The blockage of the action of collagenase 
was confirmed by the detection of diminished degradation products (aA ) of 
collagen by the presence of inhibitor (Fig. 6). The ability of the inhibitors (A 
y 
, S [ 
SA[ 
a [ 
aA[ 
I BF 
1 2 3 4 5 
Fig. 6. Comparison of hydrolysis of native 
collagen by collagenase with or without 
added inhibitor. Acid soluble guinea pig 
skin collagen, 80 fIg, was incubated with 
70 mU tadpole collagenase or 30 mU chick 
bone collagenase in, 100 ,ul of Tris-NaCI-
CaCI. buffer containing 0.25 M D-glucose 
in the absence or presence of 40.8 mIU 
inhibitor for 60 h at 20 °C (2 and 3) or 
26 °C (1, 4 and 5). After termination of 
the enzyme reaction by adding 20,u1 of 
0.2 M EDT A, SDS-polyacrylamide gel 
electrophoresis was performed at pH 8.3. 
BF, buffer front. 1, buffer; 2, tadpole col-
lagenase; 3, tadpole collagenase with in-
hibitor ; 4, chick bone collagenase and 5, 
chick bone collagenase with inhibitor. 
and B) to inhibit neutral proteases other than collagenase was further investigated 
using 3H-labeled heat-denatured polymeric collagen as a substrate (Table 3). 
Both preparations of inhibitor blocked the gelatinolytic activity of tadpole col-
lagenase, chick skin gelatinase, and human granulocyte gelatinase, while that 
of bacterial collagenase was unaffected by the inhibitor. No other proteases 
examined were affected by the inhibitor, with the exception that tryptic activity 
against gelatin was blocked by the inhibitor. A slight inhibition of plasmin was 
ascribed to the inhibitory effect of inhibitor on urokinase which was added to 
the plasmin preparation to activate plasminogen (T able 3). In other experiments, 
purified tadpole collagenase (37 mU and 54 mU) was incubated with Peptide P 
(final 2.5 X 10-4 M) for 44 h at 37 °C in the absence or presence of inhibitor 
(164 mIU). The inhibitor blocked the peptidase activity by 94 Ofo. 
Stability of Collagenase Inhibitor 
The collagenase inhibitor was heat stable. About 90 Ofo of its inhibitory activity 
was retained after treatment at 90 °C for 5 min. Sensitivity of the inhibitor to 
protease was also examined. Since the inhibitor was found to block the tryptic 
activity against gelatin (Table 3), the inhibitor was preincubated with various 
amounts of chymotrypsin. After destroying chymotryptic activity with chymo-
statin, the reaction mixture was assayed for remaining inhibitory activity. As 
shown in Table 4, the inhibitor was sensitive to chymotrypsin, indicating that 
the inhibitory activity is strongly associated with a protein component. 
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Table 3. Action of collagenase inhibitor on neutral proteases. The indicated amounts of 
various collagenases and neutral proteases were incubated with 200 flg of 3H-labeled heat-
denatured polymeric collagen in a final volume of 200 fll (Tris-NaCl-CaCI2 buffer) at 37 DC 
for 1-43 h with or without added inhibitor (53 mIU, 50 fll). After termination of the enzyme 
reaction by adding two volumes of dioxane, the radioactivity in the supernatant was deter-
mined (average of duplicate experiments) 
Gelatinolytic activity 
Enzyme source Amount Control + Inhibitor Inhibition 
(ng) (munits) (munits) (%) 
Collagenase 
tadpole skin 3.2 8.4 0'" 100 
Cl. histolyticum 0.5 79 82'" 0 
5.0 788 775 1 
5.05 '" 834 958 0 
Gelatinase 
chick skin
' 
50 fll 24 4 85 
human granulocyte 2 5 fll 73 35'" 52 
Trypsin 0.4 225 20 91 
2.0 1360 564'" 59 
Chymotrypsin 3 5.0 27 37 0 
10.0 62 59 4 
Elastase, pancreatic 5.0 14 13'" 6 
Plasmin' 10 fll 22 19 12 
20 fll 37 33 10 
1 46.2 units/OD,so nm using gelatin as a substrate (Sunda and Nagai, 1980). 
215.0 units/OD,so nm using gelatin as a substrate (Kobayashi and Nagai, 1978). 
3 Pretreated with 2.5 x 10--' M TLCK for 1 h at room temperature. 
-, 6.7 flmol/min· mg protein using tosyl-L-arginine methylester as a substrate (after activa-
tion with urokinase at 37 DC for 15 min). 
5 Pretreated with 31 mM N-ethylmaleimide. 
". 82 mIU inhibitor was employed. 
Table 4. Effect of chymotrypsin on the collagenase inhibitor, 107 mIU /100 fll of collagenase 
inhibitor was preincubated with various concentrations of TLCK-treated chymotrypsin for 
1.5 h at 37 DC, Chymotryptic activity was destroyed by adding chymostatin (10 flg/10 pI), 
then 15 fll of 27 mU tadpole collagenase was added and the final volume was adjusted to 
200 fll with Tris-NaCl-CaCI2 buffer. 190 pI of the mixture was assayed for collagenase 
activity using HC-labeled collagen fibrils as a substrate 
Con. of chymotrypsin Inhibitor Enzyme Inhibition 
during preincubation activity 
(ng) (mIU) (mU) (%) 
0 0 25.9 
0 107 9.8 62 
10 107 12.3 53 
100 107 12.7 51 
1000 107 16.3 37 
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Discussion 
It has generally been understood that extracellular degradation of collagen 
fibers is initiated through the action of specific collagenase. As shown in Figure 1, 
cartilaginous explants produce neither active nor latent collagenase during cul-
ture period, regardless of the stages examined, while the explants of bony tissue 
including marrow cells begin to produce latent collagenase at around stage 38 
and later. It is possible that, during matrix transition from cartilage to bone, the 
degradation of cartilage matrix collagen depends on collagenase activity produced 
by invading bone marrow-derived cells. The collagenase was found as an inactive 
form in culture media which could be easily activated by simple dialysis against 
3 M NaI in the cold. This suggests that the latent form of the enzyme is an 
enzyme-inhibitor complex and dissociated into active enzyme and a dialyzable 
component which has inhibitory activity. The results concur well with previous 
reports by Shinkai and Nagai (1977). On the other hand, during development, 
production of non-dialyzable collagenase inhibitory activity, distinct from the 
dialyzable inhibitor, precedes the production of latent collagenase. The col-
lagenase inhibitory activity is most remarkable at the site of active matrix transi-
tion. These results suggest that collagenase activity at the region of osteo-chondral 
transition is regulated possibly by multistep process involving conversion of 
latent collagenase to active form as well as modification of the resultant enzyme 
activity by some other regulating principle(s) such as inhibitors reported here. 
Since degradation of cartilage matrix must proceed in parallel with deposition of 
osteoid matrix, such multi-step process would provide for discrete control of 
collagenolytic activity and allow collagen resorption only under those conditions 
in which active collagenase exceeds local inhibitory capacity. 
The collagenase inhibitors (A and B) produced by chick growth cartilage are 
cationic proteins with the same molecular weight of approximately 25,000 but 
slight difference in molecular charge. The growth cartilage inhibitor differs in 
apparent molecular weight from serum inhibitors (Nagai, 1973; Werb et aL, 
1974; Woolley et aL, 1976) and from cartilage anti-invasion factor (Kuettner et 
aL, 1976). The inhibitor has much higher collagenase inhibiting capacity than 
lysozyme (Sakamoto et aL, 1974). It seems quite similar to inhibitors from rabbit 
cranial bone (Sellers and Reynolds, 1977), human skin fibroblasts (Welgus et aL, 
1979) and human tendon (Vater et aL, 1979). The inhibitor is heat-stable, but 
sensitive to chymotrypsin. It blocks the action of collagenase on both recon-
stituted collagen fibrils and collagen in solution. Although kinetic studies on the 
inhibition of collagenase have difficulties mainly because of restricted range of 
adequate substrate concentration, the dose-response curve of purified inhibitor 
and collagenase (Fig. 4) suggests that the inhibition is stoichiometric. Moreover, 
a fairly good linearity with time course of the action of inhibitor is obtained 
during the assay period. 
The inhibitor has a broad specificity against neutral proteases as summarized in 
Tables 2 and 3. It blocks the activity of collagenases from tadpole skin, chick 
bone and skin and from human granulocytes. Human granulocyte and chick skin 
gelatinases which may participate in the post-collagenase catabolism of collagen 
(Sunada and Nagai, 1980) are also inhibited by the inhibitor, as reported (Sel-
lers et al., 1979). It is of interest that the inhibitor blocks tryptic activity against 
gelatin, when assayed at enzyme concentrations similar to collagenase, but not 
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chymotryptic activity. The results described above suggest that the inhibitors 
reported here may participate in multi-functional regulations of the collagen-
degrading enzyme system. In addition, the findings of the maximum production 
of inhibitors at the growth plate may support a hypothesis that the inhibitors are 
functioning at the proximate region of selective cartilage resorption and newly 
forming osteoid tissue where degenerating hypertrophic chondroblasts synthesize 
both type I and II collagens (Gay et aI., 1976; von der Mark, 1977) and the 
degradation rate of type II collagen is increased by the presence of other types of 
collagen (Hayashi et aI., 1980b). 
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